期刊文献+

我院2008—2010年口服降糖药的用药分析 被引量:3

Analysis of Oral Hypoglycemic Agents Used in Our Hospital during 2008—2010
下载PDF
导出
摘要 目的了解医院口服降糖药的使用情况,促进合理用药。方法对重庆医科大学附属第二医院2008年至2010年口服降糖药的应用频率、消耗金额进行统计分析。结果该院口服降糖药的消耗金额逐年增长,其中二甲双胍增幅较大;临床最常用的口服降糖药是二甲双胍、阿卡波糖和格列吡嗪。结论医院口服降糖药的使用呈增长趋势。 Objective To evaluate the application status of oral hypoglycemic agents used in the hospital for promoting rational drug use.Methods The frequency and sum of money in consumption of oral hypoglycemic agents during 2008—2010 were statistically analyzed.Results The sum of money in consumption of oral hypoglycemic agents in the hospital was increased year by year,in which,the increment of metformin was maximum.The commonest used oral hypoglycemic agents in clinic were metformin,glipizide and pioglipazong.Conclusion The use of oral hypoglycemic agents presents the increasing trend.
作者 朱寅
出处 《中国药业》 CAS 2011年第9期35-36,共2页 China Pharmaceuticals
关键词 口服降糖药 用药频度 用药分析 oral hypoglycemic agent DDDs medication analysis
  • 相关文献

参考文献4

二级参考文献11

  • 1姚春芳.降血糖药格列美脲首次获得批准[J].国外医学:药学分册,1996,23(1):59-59.
  • 2Hatorp V,Huang WC,Strange P.Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes[].The Journal of Clinical Endocrinology.1999
  • 3Vinambres C,Villanueva-penacarrillo ML,Malaisse WJ.Repaglinide preserves nutrient-stimulated biosynthetic activity in rat pancreatic islets[].Pharmacological Research.1996
  • 4Marbury TC,Hatorp V,Damsbo P,et al.Repaglinide can be given in the flexible preprandial dosing regimen in patients with type 2 diabetes[].Diabetes.1998
  • 5Goldberg RB,Brodows RG,Damsbo P.A randomized, placebocontrolled trial of repaglinide in the treatment of type 2 diabetes[].Diabetes.1998
  • 6Berger S,Strange P.Repaglinide, a novel oral hypoglycemic agent in type 2 diabetes: A randomized, placebo-controlled, double-blind, fixed-dose study[].Diabetes.1998
  • 7Fuhlendorff J,Rorsman P,Kofod H,et al.Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes[].Diabetes.1998
  • 8Owens DR,Luzio SD,Coates PA.Insulin secretion and sensitivity in newly diagnosed NIDDM Caucasions in the UK[].Diabetic Medicine.1996
  • 9Marbury TC,Strange P.Multicenter, randomized comparison of the therapeutic effects of long-term use of repaglinide with glyburide in type 2 diabetes[].Diabetes.1998
  • 10Damsbo P,Clauson P,Marbury TC,et al.A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetes patients[].Diabetes Care.1999

共引文献47

同被引文献30

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部